Find the lowest price from 7,500+ FDA-registered pharmacies. Save up to 90%.
⭐ 4.7/5 Customer Rating
🏅 FDA-Registered Pharmacies
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
Blocks histamine H1 receptors directly at target tissues — a second line of action that manages symptoms even when some mediator release occurs.
Methimazole transdermal gel is a compounded medication applied to the inner ear of cats to treat hyperthyroidism — eliminating the need for stressful oral pilling.
Search 7,500+ licensed pharmacies to find the best value, closest location, and fastest turnaround for
.
Methimazole blocks thyroid hormone synthesis by inhibiting thyroid peroxidase, reducing T3 and T4 production.
The commercially available tablet form is difficult to administer to cats. Compounded transdermal gel applied to the inner ear pinnae improves compliance and avoids the stress of oral dosing.
Methimazole transdermal gel is one of the most commonly compounded veterinary medications in the United States. Feline hyperthyroidism is the most common endocrine disorder in cats, and while oral methimazole tablets are available commercially, many cats resist pilling, making compliance a serious challenge for pet owners.
Compounding pharmacies prepare methimazole as a transdermal gel that is applied to the hairless inner surface of the ear pinnae (ear flap). The medication absorbs through the skin and into the bloodstream, achieving therapeutic drug levels without oral administration. This formulation dramatically improves owner compliance and reduces stress for both the cat and the owner.
Methimazole inhibits thyroid peroxidase, an enzyme essential for the synthesis of thyroid hormones T3 (triiodothyronine) and T4 (thyroxine). By blocking this enzyme, methimazole reduces the production of thyroid hormones, bringing circulating levels back into the normal range.
In hyperthyroid cats, excess thyroid hormone accelerates metabolism, causing weight loss, increased appetite, vomiting, and cardiovascular complications including hypertrophic cardiomyopathy. Successful methimazole therapy normalizes these parameters over several weeks of treatment.
Methimazole transdermal gel is used almost exclusively for the long-term management of feline hyperthyroidism, a condition caused by a benign tumor (adenoma) of the thyroid gland that leads to excessive thyroid hormone production.
It is typically used as a medical management option when surgical thyroidectomy or radioactive iodine therapy (I-131) is not pursued due to cost, patient risk, or owner preference. Many cats remain on methimazole for life.
BIND THIS TO: Mechanism Text CMS field (Rich Text). Then delete this paragraph and add a Rich Text element instead.
⚠️ Dosing should be determined by your prescriber. The information below is general guidance only.
Common side effects include mild skin irritation at the application site on the ear. Some cats develop self-limiting vomiting or decreased appetite, particularly early in treatment. Less commonly, cats may develop facial excoriation (scratching at the face), thrombocytopenia, or elevated liver enzymes.
Serious but rare side effects include agranulocytosis (low white blood cell count), which requires discontinuation of the medication. Routine blood work monitoring is recommended every 3–6 months during long-term therapy.
Submit a quote request to find the lowest price. Quotes delivered to your inbox.
Find Lowest Price.png){kind=spacer}
Prevents mast cells from degranulating — stopping the release of histamine, leukotrienes, and other inflammatory mediators before they trigger symptoms.
